共 50 条
REVIEW OF SMALL CELL CARCINOMA OF THE KIDNEY WITH FOCUS ON CLINICAL AND PATHOBIOLOGICAL ASPECTS
被引:18
|作者:
Kuroda, Naoto
[1
]
Imamura, Yoshiaki
[2
]
Hamashima, Takeru
[3
]
Ohe, Chisato
[4
]
Mikami, Shuji
[5
]
Nagashima, Yoji
[6
]
Inoue, Keiji
[7
]
Perez-Montiel, Delia
[8
]
Petersson, Predrik
[9
]
Michal, Michal
[10
]
Hes, Ondrej
[10
]
机构:
[1] Kochi Red Cross Hosp, Dept Diagnost Pathol, Kochi 7808562, Japan
[2] Univ Fukui Hosp, Div Surg Pathol, Fukui, Japan
[3] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pathol, Toyama 930, Japan
[4] Kansai Med Univ, Hirakata Hosp, Dept Pathol, Osaka, Japan
[5] Keio Univ Hosp, Div Diagnost Pathol, Tokyo, Japan
[6] Yokohama City Univ, Grad Sch Med, Dept Mol Pathol, Yokohama, Kanagawa 232, Japan
[7] Kochi Univ, Kochi Med Sch, Dept Urol, Kochi 780, Japan
[8] Natl Inst Canc Mexico, Dept Pathol, Mexico City, DF, Mexico
[9] Natl Univ Hosp Syst, Dept Pathol, Singapore, Singapore
[10] Charles Univ Prague, Med Fac Hosp, Dept Pathol, Plzen, Czech Republic
关键词:
small cell carcinoma;
kidney;
dismal prognosis;
SINGLE-INSTITUTION EXPERIENCE;
OF-THE-LITERATURE;
NEUROENDOCRINE TUMORS;
D O I:
10.5114/PJP.2014.42664
中图分类号:
R36 [病理学];
学科分类号:
100104 ;
摘要:
Small cell carcinoma (SmCC) of the kidney is extremely rare. In this article, we present a review of SmCC of the kidney with the focus on clinical and pathobiological aspects. Macroscopically, this tumor often shows a bulky mass extensively replacing the renal parenchyma with vascular invasion and metastasis to lymph nodes. Histologically, the tumor is composed of small cells with scant cytoplasm, round to oval nuclei, finely granular chromatin and inconspicuous nucleoli. Rosette or tubular formation may be present Immunohistochemically, neoplastic cells show variable positivity for neuron-specific enolase, chromogranin A, synaptophysin, CD57 (Leu7) and CD56. A dot-like staining pattern for cytokeratin may also be observed. An electron microscopic examination may identify electron-dense neurosecretory granules in the cytoplasm. As a therapeutic option, nephrectomy and systemic chemotherapy should be considered. However, despite multimodal therapy, most patients have a dismal outcome and die of widely metastatic disease within one to two years. As there are limited genetic data on SmCC of the kidney, a large series studying this will be needed in the future.
引用
收藏
页码:15 / 19
页数:5
相关论文